GIORGINO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 31.835
AS - Asia 12.901
EU - Europa 11.335
SA - Sud America 3.531
Continente sconosciuto - Info sul continente non disponibili 1.200
AF - Africa 565
OC - Oceania 34
Totale 61.401
Nazione #
US - Stati Uniti d'America 31.286
SG - Singapore 5.377
IT - Italia 4.144
CN - Cina 2.864
BR - Brasile 2.761
HK - Hong Kong 1.584
SE - Svezia 1.298
RU - Federazione Russa 1.085
DE - Germania 1.016
VN - Vietnam 852
UA - Ucraina 827
FI - Finlandia 820
FR - Francia 811
GB - Regno Unito 579
IN - India 456
BD - Bangladesh 393
CA - Canada 250
AR - Argentina 243
ID - Indonesia 220
IQ - Iraq 177
MX - Messico 142
TR - Turchia 141
NL - Olanda 126
EC - Ecuador 123
PK - Pakistan 117
CI - Costa d'Avorio 116
CO - Colombia 114
ZA - Sudafrica 109
JP - Giappone 104
VE - Venezuela 97
PL - Polonia 96
BE - Belgio 91
SA - Arabia Saudita 90
AT - Austria 83
ES - Italia 80
IE - Irlanda 79
MA - Marocco 68
MY - Malesia 64
UZ - Uzbekistan 63
PH - Filippine 58
TN - Tunisia 58
CL - Cile 55
EG - Egitto 43
JM - Giamaica 39
PE - Perù 39
JO - Giordania 37
PY - Paraguay 37
AE - Emirati Arabi Uniti 35
LT - Lituania 31
DZ - Algeria 30
KE - Kenya 29
KR - Corea 29
NP - Nepal 28
UY - Uruguay 28
CH - Svizzera 27
AU - Australia 26
ET - Etiopia 26
BO - Bolivia 25
CZ - Repubblica Ceca 25
LB - Libano 25
IL - Israele 24
CR - Costa Rica 21
AZ - Azerbaigian 20
GR - Grecia 19
KG - Kirghizistan 18
KZ - Kazakistan 16
OM - Oman 15
SN - Senegal 15
HN - Honduras 14
LY - Libia 14
PA - Panama 14
PS - Palestinian Territory 14
DO - Repubblica Dominicana 12
TH - Thailandia 12
AL - Albania 11
GT - Guatemala 11
NI - Nicaragua 11
PT - Portogallo 11
RS - Serbia 11
SY - Repubblica araba siriana 11
BG - Bulgaria 9
HU - Ungheria 9
IR - Iran 9
TT - Trinidad e Tobago 9
RO - Romania 8
AM - Armenia 7
EU - Europa 7
KW - Kuwait 7
NZ - Nuova Zelanda 7
QA - Qatar 7
BY - Bielorussia 6
GY - Guiana 6
HR - Croazia 6
NG - Nigeria 6
SV - El Salvador 6
TW - Taiwan 6
AO - Angola 5
BB - Barbados 5
GE - Georgia 5
SC - Seychelles 5
Totale 60.105
Città #
Ashburn 2.923
Singapore 2.875
Fairfield 2.564
San Jose 2.284
Woodbridge 2.146
Jacksonville 1.875
Chandler 1.866
Hong Kong 1.558
Houston 1.509
Milan 1.337
Cambridge 1.054
Seattle 990
Ann Arbor 973
Nyköping 969
Council Bluffs 832
Wilmington 811
Beijing 651
New York 536
Lauterbourg 511
Roxbury 508
Rome 503
Lawrence 499
Dearborn 483
Nanjing 467
Los Angeles 448
Helsinki 388
Dallas 384
Bari 383
Boardman 370
Des Moines 312
Ho Chi Minh City 273
Columbus 268
Santa Clara 240
São Paulo 224
Inglewood 178
Princeton 175
Brooklyn 171
Buffalo 167
Hanoi 161
San Diego 138
London 136
Munich 133
Chicago 132
Nanchang 130
Falkenstein 127
Jakarta 127
Hebei 125
Abidjan 116
Shenyang 111
Figino 107
Rio de Janeiro 102
Moscow 93
Orem 92
Brussels 87
San Francisco 87
Tokyo 86
Phoenix 85
Frankfurt am Main 84
Jiaxing 84
Baghdad 82
Turin 82
Paris 81
Tianjin 80
Belo Horizonte 77
Nuremberg 77
Dublin 74
Warsaw 74
Montreal 71
Guangzhou 69
Pune 68
Chennai 67
Atlanta 66
Naples 64
Denver 63
Dong Ket 63
Hefei 62
Curitiba 59
Changsha 58
Jinan 56
Tashkent 54
Amsterdam 51
Johannesburg 50
Redwood City 49
Porto Alegre 45
Toronto 45
Kunming 44
Mexico City 43
Quito 42
The Dalles 42
Shanghai 41
Brasília 40
Campinas 40
Manchester 40
Haiphong 39
Boston 38
Stockholm 38
Dhaka 37
Hyderabad 37
Lahore 36
Vienna 36
Totale 39.328
Nome #
Effects of CPAP on testosterone levels in patients with obstructive sleep apnea: a meta-analysis study 640
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 395
Efficacy and safety of once- weekly dulaglutide versus insulin glargine in patients with type 2 Diabetes on metformin and glimepiride (AWARD-2) 368
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 319
Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy 280
Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity 258
Long-term exposure of pancreatic β-cells to palmitate results in SREBP-1C-dependent decreases in GLP-1 receptor signaling via CREB and AKT and insulin secretory response 233
Abnormalities of insulin-like growth factor-l Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis 225
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 224
Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy 221
GLP-1: a new approach for type 2 diabetes therapy 219
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial 219
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases 217
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy 215
PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia 213
Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis 212
Wound healing in diabetes: hemorheological and microcirculatory aspects. 206
Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis 206
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 201
The p66Shc Protein Controls Redox Signaling and Oxidation-Dependent DNA Damage in Human Liver Cells 196
Diabetes and cancer: pathophysiological fundamentals of a 'dangerous affair' 194
Insulin and Insulin Receptors in Adipose Tissue Development 189
GLP-1 Receptor Agonist Added to Insulin versus Basal-plus or Basal-bolus Insulin Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis 184
Irisin Increases the Expression of Anorexigenic and Neurotrophic Genes in Mouse Brain 183
Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysin63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy 183
Clinical view on the need to develop new anti-diabetic drugs 182
Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan-L trial 182
Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage? 182
The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells 181
GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells 180
Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes Trials 177
Diabetic foot: clinical approach 174
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 174
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: Clinical consequences and strategies for improvement 173
Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment 171
Rare diseases in clinical endocrinology: A taxonomic classification system 171
Interventional therapy in diabetic foot: Risk factors, clinical events and prognosis at one year follow-up (a study of 103 cases) 169
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 169
Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis 169
Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism 168
Association between Follicular Fluid Leptin and Serum Insulin Levels in Nonoverweight Women with Polycystic Ovary Syndrome 168
Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism 167
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 166
Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway. 165
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 165
NANOG plays a hierarchical role in the transcription network regulating the pluripotency and plasticity of adipose tissue-derived stem cells 163
Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane 162
A family history of Type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women 161
A master course on "Methodologies for bio-medical research in diabetes". 159
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis 158
RAS/BRAF mutational status in familial non‑medullary thyroid carcinomas: A retrospective study 158
Relationship between risk factors and mortality in type 1 diabetic patients in europe: The eurodiab prospective complications study (PCS) 158
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies 158
Abnormalities of cardiac insulin signaling in experimental diabetes 157
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. 157
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. 156
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 156
Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial 155
The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β-cell survival and insulin secretion 153
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. 152
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study 152
Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 152
Chronic palmitate excess results in reduced exendin-4 action and signalling via CREB and Akt in pancreatic beta cells 151
Effects of Extra Virgin Olive Oil Polyphenols on Pancreatic Beta-Cell Function and Survival 151
Effects of extra virgin olive oil polyphenols on beta-cell function and survival 151
Adipose tissue precursor cells 150
Ubc9 regulation of glucose transport in 3T3-L1 adipocytes is differentiation-dependent. 149
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: A cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 149
The Sentiment Analysis of Tweets as a New Tool to Measure Public Perception of Male Erectile and Ejaculatory Dysfunctions 149
Association between physical activity estimated by the International physical activity questionnaire and UKPDS cardiovascular risk in score type 2 diabetes. 148
Adipose Tissue Function and Dysfunction: Organ Cross-Talk and Metabolic Risk 147
Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects 147
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 146
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study 146
Characterization of the gut microbiota and metabolome in healthy and unhealthy obese patients 145
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 145
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: A comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program 145
Carriers of the TCF7L2 rs7903146 variant with GMD have an increate risk of developing impaired glucose regulation after pregnancy. 144
Biological specificity of visceral adipose tissue and therapeutic intervention 144
Effect of family history of type 2 diabetes on white blood cell count in adult women 144
IGF-I and IGF-I receptor: implications in the pathophysiology of thyroid cancer 143
Glucagon-Like Peptide-1 Counteracts Oxidative Stress-Dependent Apoptosis of Human Cardiac Progenitor Cells by Inhibiting the Activation of the c-Jun N-terminal Protein Kinase Signaling Pathway 143
Comparison of Distinct GLP-1 Receptor Agonists in Palmitate-induced Incretin Resistance of Pancreatic Beta Cells 142
Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection 142
The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study 141
A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial 140
Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: A systematic review and meta-analysis 140
Irisin Enhances Pancreatic Beta-Cell Survival and Insulin Secretion and Can Mediate the Metabolic Cross Talk between the Skeletal Muscle and Endocrine Pancreas 140
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study 139
Apoptotic and survival signals triggered by high glucose in human mesangial cells. 139
Decreased IRS phosphorylation and altered Erk activation in osteoblasts from osteoporotic subjects. 139
Abnormalities in IGF-I signalling and impaired cell proliferation in osteoblasts from patients with osteoporosis. 139
Low dehydroepiandrosterone circulating levels in premenopausal obese women with very high body mass index 139
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis 139
Efficacy of Vandetanib in treating locally advanced or metastatic medullary thyroid carcinoma according to RECIST Criteria: A systematic review and meta-analysis 139
Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity 138
Differences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humans. 138
Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia. 138
Effects of irisin on leptin and ghrelin secretion and expression of the major appetite regulators in mouse brain 138
Functional loss of pancreatic islets in type 2 diabetes: How can we halt it? 138
Totale 17.765
Categoria #
all - tutte 253.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 253.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.788 0 0 31 214 127 179 106 200 252 222 581 876
2022/20235.254 761 491 261 471 651 762 78 575 978 40 101 85
2023/20241.834 158 380 107 128 179 413 39 157 23 50 13 187
2024/20258.840 128 124 710 295 233 907 667 825 445 481 1.334 2.691
2025/202621.006 2.727 841 1.169 2.139 2.105 1.194 2.477 652 2.009 2.310 825 2.558
2026/20273.712 1.295 1.438 979 0 0 0 0 0 0 0 0 0
Totale 61.401